About TMRW
TMRW is a private company based in New York, New York. It has reported $184,828,915 raised in four offerings on Form D since December 2019. Its chief executive is Emily Conley.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 28, 2024 | Jul 12, 2024 | $28,172,940of $29.9M target | 69 | $408K | EquityRule 506(b) | Form D ↗ |
| Jun 30, 2021 | Jul 15, 2021amended May 13, 2022 | $100,155,975of $102.2M target | 59 | $1.6M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 3, 2021 | Feb 12, 2021 | $20,000,000fully sold | 35 | $571K | Debt, OptionsRule 506(b) | Form D ↗ |
| Dec 6, 2019 | Dec 23, 2019amended May 19, 2020 | $36,500,000fully sold | 34 | $1.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, four offerings | $184,828,915 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on TMRW's Form D filed Jul 12, 2024.
Earlier filings also listed William Schoolcraft (director, last listed Apr 2026), Louis Villalba (chief executive officer and director, last listed Apr 2026), Greg Eisner (director, last listed Apr 2026), Emily Drabant Conley (director, last listed Apr 2026), Tara Comonte (executive officer and director, last listed May 2022) and Melanie Goldey (executive officer, last listed May 2022).
Sources
- SECTMRW Life Sciences, Inc. Form D, filed Jul 15, 2021
- SECTMRW Life Sciences, Inc. Form D, filed Dec 23, 2019
- SECTMRW Life Sciences, Inc. filing history
- CompanyAbout TMRW Life Sciences
- CompanyTMRW leadership team
- PressTMRW Life Sciences appoints Tara Comonte as chief executive officer
- PressTMRW Life Sciences Series D financing